FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

cnbc.com/2025/06/18/fda-approves-gilead-hiv-prevention-injection-lenacapavir.html

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

This story appeared on cnbc.com, 2025-06-18 18:30:18.
The Entire Business World on a Single Page. Free to Use →